| Patents for C07K 4 - Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof (2,102) |
|---|
| 03/20/2001 | US6204362 Method of purifying whey of lactic acid fermentation by electrodialysis |
| 03/14/2001 | EP1082289A1 Methods for identifying novel multimeric agents that modulate receptors |
| 03/08/2001 | WO1999064047A8 Novel antiviral compounds |
| 03/08/2001 | WO1999063930A8 Novel angiotensin receptor modulators and their uses |
| 03/07/2001 | EP1080080A1 Novel therapeutic agents that modulate neurokinin receptors |
| 02/22/2001 | WO1999063996A8 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors |
| 02/21/2001 | EP0725825B1 Peptides that elicit neutralizing antibodies against genetically divergent hiv-1 strains |
| 02/07/2001 | EP1073891A2 Method of prediciting receptor modulating activity |
| 02/07/2001 | EP1073475A2 Improvements in or relating to diagnostic/therapeutic agents |
| 01/24/2001 | EP1070254A1 Compositions and methods for detecting ligand-dependent nuclear receptor and coactivator interactions |
| 01/23/2001 | US6177407 Specifically ischemic cardiac tissue, by administering at least one of angiotensinogen and specified sequences encoding angiotensin i, its analogues and fragments, angiotensin ii (aii) analogues or fragments, and aii at2 type 2 receptor |
| 01/18/2001 | WO1999064049A9 Novel antibacterial agents |
| 12/12/2000 | CA2014948C Genes coding for a protein having human macif activity, expression vectors containing said genes, transformant cells and proteins having human macif activity |
| 11/29/2000 | EP1055125A2 Interaction between cyclin d1 and steroid receptor co-activators |
| 11/21/2000 | US6150087 Non-hepatitis a or b virus polypeptide which is capable of illiciting immune response with hepatitus virus antibodies, for the treatment of and prevention of viral infections |
| 11/08/2000 | EP1049709A1 Novel peptides having biological activity |
| 11/02/2000 | EP1047707A1 Isolated, polypeptides which bind to hla-a29 molecules, nucleic acid, the molecules encoding these, and uses thereof |
| 10/26/2000 | WO2000062813A2 Cationic peg-lipids and methods of use |
| 10/26/2000 | CA2370690A1 Cationic peg-lipids and methods of use |
| 10/19/2000 | WO2000061813A1 A second mammalian tankyrase |
| 10/19/2000 | CA2360318A1 A second mammalian tankyrase |
| 10/18/2000 | EP1044983A1 Antibiotic tkr2999, process for the preparation thereof and microbe |
| 10/12/2000 | WO1999064039A9 Bradykinin antagonists |
| 10/05/2000 | WO2000005249A3 Synthetic peptides and methods of use for autoimmune disease therapies |
| 10/03/2000 | US6126939 Anti-inflammatory dipeptide and pharmaceutical composition thereof |
| 09/21/2000 | WO2000020598A9 Peptides useful for reducing symptoms of toxic shock syndrome and septic shock |
| 09/20/2000 | EP1036798A1 Peptides having anti-cell adhesion activity |
| 09/14/2000 | WO1999063999A8 H1-histamine receptor antagonists |
| 08/31/2000 | WO2000018910A9 Moraxella catarrhalis protein, nucleic acid sequence and uses thereof |
| 08/10/2000 | WO1999063936A9 Novel therapeutic agents that modulate endothelin receptors |
| 08/03/2000 | WO2000044776A1 Alpha-conotoxin peptides |
| 08/03/2000 | CA2743116A1 Alpha-conotoxin peptides with a 4/7 motif |
| 08/01/2000 | US6096871 Polypeptides altered to contain an epitope from the Fc region of an IgG molecule for increased half-life |
| 07/28/2000 | CA2296311A1 Enzymatic hydrolysate of milk proteins |
| 07/27/2000 | WO1999066944A9 Methods for identifying novel multimeric agents that modulate receptors |
| 07/27/2000 | WO1999064033A9 Phosphodiesterase-v modulator drugs and their uses |
| 07/20/2000 | WO2000042066A1 Method of purifying whey of lactic acid fermentation by electrodialysis |
| 07/20/2000 | WO2000002902A9 Novel inhibitors of angiogenesis and tumor growth |
| 07/20/2000 | WO1999064048A9 Inhibitors of hiv reverse transcriptase |
| 07/19/2000 | EP1019360A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS |
| 07/19/2000 | EP1019075A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS |
| 07/13/2000 | DE19845405C2 Arylsubstituierte Propanolaminderivate und deren Verwendung Aryl-substituted Propanolaminderivate and their use |
| 07/06/2000 | WO1999064035A9 β2-ADRENERGIC RECEPTOR AGONISTS |
| 07/05/2000 | EP1015495A2 Peptide sequences as hinge regions in proteins like immunoglobulin fragments and their use in medicine |
| 06/29/2000 | WO1999064034A9 β2-ADRENERGIC RECEPTOR AGONISTS |
| 06/28/2000 | EP1013284A2 Purified forms of dnase |
| 06/14/2000 | EP1007095A2 Chimeric toxins for targeted therapy |
| 06/14/2000 | EP1006785A1 Antimicrobial proteins |
| 06/13/2000 | US6075122 A peptide for the detection, monitoring, and treatment of cancer in animals; anticarciongenic agents |
| 06/07/2000 | EP1005356A1 Novel antibacterial agents |
| 06/06/2000 | US6072045 Chimeric isoprenoid synthases and uses thereof |
| 05/31/2000 | EP1003541A1 Inhibitors of hiv reverse transcriptase |
| 05/31/2000 | EP1003540A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS |
| 05/04/2000 | WO1999064038A9 Novel analgesic agents |
| 05/04/2000 | WO1999064031A9 β2-ADRENERGIC RECEPTOR AGONISTS |
| 05/04/2000 | WO1999063988A9 Inhibitors of nitric oxide synthase |
| 05/02/2000 | CA2011878C Immunogenic regions on the e7 protein of human papillomavirus type 16 |
| 04/27/2000 | WO1999063933A9 Multivalent agonists, partial agonists and antagonists of the gaba receptors |
| 04/20/2000 | WO1999064046A9 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5-ht3 receptors |
| 04/20/2000 | WO1999064000A9 Novel therapeutic agents that modulate neurokinin receptors |
| 04/20/2000 | DE19845405A1 Arylsubstituierte Propanolaminderivate und deren Verwendung Aryl-substituted Propanolaminderivate and their use |
| 04/19/2000 | CN1251041A Fine tuned progegrins |
| 04/13/2000 | WO2000020598A1 Peptides useful for reducing symptoms of toxic shock syndrome and septic shock |
| 04/13/2000 | WO2000020392A1 Aryl-substituted propanolamine derivatives, methods for their production, medicaments containing said compounds and their use |
| 04/13/2000 | CA2345023A1 Peptides useful for reducing symptoms of toxic shock syndrome and septic shock |
| 04/06/2000 | WO2000018910A1 Moraxella catarrhalis protein, nucleic acid sequence and uses thereof |
| 04/06/2000 | CA2344622A1 Moraxella catarrhalis protein, nucleic acid sequence and uses thereof |
| 04/05/2000 | EP0990156A1 Cyclic peptide libraries and methods of use thereof to identify binding motifs |
| 04/05/2000 | EP0989857A1 Novel therapeutic agents that modulate enzymatic processes |
| 03/23/2000 | WO1999063983A9 MULTIBINDING AGENTS THAT MODULATE PPARη AND RXR RECEPTORS |
| 03/16/2000 | WO1999064047A9 Novel antiviral compounds |
| 03/16/2000 | WO1999063929A9 Multibinding inhibitors of microsomal triglyceride transferase protein |
| 03/02/2000 | WO1999064054A9 Multibinding inhibitors of topoisomerase |
| 03/02/2000 | WO1999064043A9 Muscarinic receptor antagonists |
| 03/02/2000 | WO1999063937A3 Multivalent macrolide antibiotics |
| 03/01/2000 | EP0770091B1 Compounds for reversing drug resistance |
| 02/24/2000 | WO2000009144A1 Methods to increase blood flow to ischemic tissue |
| 02/24/2000 | CA2339330A1 Methods to increase blood flow to ischemic tissue |
| 02/16/2000 | EP0979238A1 Method of alleviating neuropathic pain |
| 02/16/2000 | CN1244769A Antimicrobial proteins |
| 02/10/2000 | WO1999063944A3 Novel therapeutic agents that modulate estrogen receptors |
| 02/10/2000 | WO1999054728A3 Method of predicting receptor modulating activity |
| 02/03/2000 | WO2000005249A2 Synthetic peptides and methods of use for autoimmune disease therapies |
| 02/03/2000 | WO1999063936A3 Novel therapeutic agents that modulate endothelin receptors |
| 02/03/2000 | WO1999063933A3 Multivalent agonists, partial agonists and antagonists of the gaba receptors |
| 02/03/2000 | WO1999063929A3 Multibinding inhibitors of microsomal triglyceride transferase protein |
| 02/03/2000 | CA2336238A1 Synthetic peptides and methods of use for autoimmune disease therapies |
| 01/27/2000 | WO1999063930A3 Novel angiotensin receptor modulators and their uses |
| 01/20/2000 | WO2000002902A1 Novel inhibitors of angiogenesis and tumor growth |
| 01/20/2000 | CA2337438A1 Novel inhibitors of angiogenesis and tumor growth |
| 01/19/2000 | EP0971726A1 Peptides for inhibiting retroviruses |
| 01/18/2000 | US6015695 Immunoglobulins devoid of light chains |
| 01/12/2000 | EP0548234B1 Cloning of chicken anaemia dna |
| 01/05/2000 | EP0673234B1 Tissue protective and regenerative compositions |
| 12/29/1999 | WO1999066944A1 Methods for identifying novel multimeric agents that modulate receptors |
| 12/29/1999 | WO1999066934A1 CYCLIC AMINO ACID COMPOUNDS, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, AND METHODS FOR INHIBITING β-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS BY USE OF SUCH COMPOUNDS |
| 12/29/1999 | CA2324475A1 Cyclic amino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting .beta.-amyloid peptide release and/or its synthesis by use of such compounds |
| 12/29/1999 | CA2319650A1 Methods for identifying novel multimeric agents that modulate receptors |
| 12/16/1999 | WO1999064055A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors |
| 12/16/1999 | WO1999064054A1 Multibinding inhibitors of topoisomerase |